Global

‡ In these countries please contact our distributor

ACTICOAT

Antimikrobiel sølvbandage

Bekæmp infektion med ACTICOAT

Bekæmp infektion

Don’t risk infection 
Whether you’re a surgeon who’s just been presented with a new case, a nurse treating a chronic wound or working in acute care, it’s your responsibility to stay in control of infection management. 
By taking control of the approach to infection management in your teams and in the products you use, you can ensure you are in control of any threats to patient well-being and reduce patient treatment times related to infection.
ACTICOAT is a range of dressings that utilize the antimicrobial properties of silver to provide an efficient and effective barrier to bacterial penetration.1, 2 Flexible, absorbent and conformable, each ACTICOAT variant is developed with properties specific to its required use.3
With ACTICOAT™, the prevention and treatment of infection starts rapidly and continues to work
ACTICOAT possesses the key characteristics of an antimicrobial dressing:
ACTICOAT is proven effective (in vitro) against 150+ gram positive/gram negative/anaerobic bacteria, fungal, yeast and resistant wound pathogens, including strains of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococcus (VRE) and bacteria containing NDM-1 carbapenemases.6, 9-11

Risiker ikke infektion 

Uanset om du er kirurg og lige har fået en ny patient, eller du er sygeplejerske og behandler et kronisk sår eller arbejder i akutafdelingen, er det dit ansvar at have styr på infektionshåndtering. 

Ved at tage kontrollen over tilgangen til infektionshåndtering i dine teams og i de produkter, du benytter, kan du sikre dig, at du har styr på trusler mod patienternes velbefindende og nedbringe antallet af patientbehandlinger som følge af infektioner.

ACTICOAT er en række bandager, der udnytter sølvs antimikrobielle egenskaber til at danne en effektiv og virkningsfuld barriere mod bakteriel indtrængning. 3 ACTICOAT-bandagerne er fleksible, absorberende og formbare, og hver enkelt variant er udviklet til at have specifikke egenskaber, der egner sig til den tilsigtede brug.1,2

Med ACTICOAT starter forebyggelsen og behandlingen af infektioner hurtigt og fortsætter med at virke.

ACTICOAT Key Characteristics of Dressing

*ACTICOAT Flex 3 og 7, ACTICOAT og ACTICOAT 7
**ACTICOAT og ACTICOAT 7

 

Referencer

1. Daubney, L; ACTICOAT Flex 7 - Evaluation of Extensibility, report reference DS.08.123.R1.
2. Smith & Nephew Data on File Report – 0403002.
3. Burrell et al., Efficacy of Silver-Coated Dressings as Bacterial Barriers in a Rodent Burn Sepsis Model. Wounds 1999; 11(4):64-71.
6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
8. Wright et al., The Comparative Efficacy of Two Antimicrobial Barrier Dressings: In-Vitro Examination of Two Controlled Release of Silver Dressings. Wounds 1998; 10(6): 179-188.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
12. Tredget et al., A Matched-Pair, Randomized Study Evaluating the Efficacy and Safety of ACTICOAT Silver-Coated Dressing for the Treatment of Burn Wounds. Journal of Burn Care and Rehabilitation 1998; 19(6): 531-537.
26. Searle and Bielby. Dressing strategies for the management of infected wounds in community wound care: impacts and implications. Poster at Wounds UK, Harrogate Nov 2010.

ACTICOAT til brandsår

In burn cases where taking control of the risk of infection is critical to patient survival, you need reliable protection against the unknown. ACTICOAT™’s unique patented silver technology helps you mitigate the risk of infection over partial and full thickness wounds.
Kills 150+ pathogens 
150+ pathogens
Broad spectrum » gram-positive bacteria » gram-negative bacteria » fungal wound pathogens 
When the source of bacterial contamination is unknown, a broad spectrum dressing proven effective (in vitro) against 150+ wound pathogens6,9-11 offers your patients the reliable protection.
Fast-acting 
ACTICOAT's proprietary silver technology means it starts working within 30 minutes, educing the opportunity for bacteria to develop antimicrobial resistance.8-11
Easy to apply and remove 
ACTICOAT Flex adapts to the contours of the body. This makes it easier for you and your team to dress wounds, no matter how large or how severe, wherever they are on the body

I tilfælde med forbrændinger, hvor det er af kritisk betydning for patientens overlevelse at få elimineret risikoen for infektion, har du behov for en sikker og pålidelig beskyttelse mod det ukendte.

Med ACTICOATs unikke patenterede sølvteknologi kan du nedbringe infektionsrisikoen i 2. og 3. grads forbrændinger.

 

ACTICOAT kills pathogensEffektiv mod 150+ patogener 

  • Bredspektret
    » grampositive bakterier
    » gramnegative bakterier
    » svampepatogener i sår.

Når kilden til bakteriel kontamination er ukendt, giver du dine patienter en forsvarlig beskyttelse med en bredspektret bandage, der har vist sig virkningsfuld (in vitro) mod 150+ sårpatogener6,9-11 


ACTICOAT starts working within 30 minutesVirker hurtigt 

ACTICOAT's patenterede sølvteknologi betyder, at den begynder at virke inden for 30 minutter ved at reducere risikoen for, at bakterier kan udvikle antimikrobiel resistens.8-11


ACTICOAT Easy to Apply IconNem at applicere

ACTICOAT Flex tilpasser sig kroppens form. Det gør det nemmere for dig og dit team at forbinde sår, uanset hvor store og alvorlige de er, og hvor på kroppen de er 40.

Referencer

6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
8. Wright et al., The Comparative Efficacy of Two Antimicrobial Barrier Dressings: In-Vitro Examination of Two Controlled Release of Silver Dressings. Wounds 1998; 10(6): 179-188.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
40. Demonstrable. 

Hospitalsbrug og akutbehandling

In emergency cases and acute care where taking control of the risk of infection is critical to patient survival, you need reliable protection against the unknown. ACTICOAT™’s unique patented silver technology helps you mitigate the risk of infection over partial and full thickness wounds.
Kills 150+ pathogens 
150+ pathogens
Broad spectrum
gram-positive bacteria 
gram-negative bacteria
fungal wound pathogens 
When the source of bacterial contamination is unknown, a broad spectrum dressing proven effective (in vitro) against 150+ wound pathogens6,9-11 offers your patients the reliable protection.
Fast-acting 
ACTICOAT's proprietary silver technology means it starts working within 30 minutes, educing the opportunity for bacteria to develop antimicrobial resistance.8-11
Easy to apply and remove 
ACTICOAT Flex adapts to the contours of the body. This makes it easier for you and your team to dress wounds, no matter how large or how severe, wherever they are on the body
Link to ACTICOAT, ACTICOAT 7, ACTICOAT Flex and Flex 7 product pages

I akutte situationer, hvor det er af kritisk betydning for patientens overlevelse at få elimineret risikoen for infektion, har du behov for en sikker og pålidelig beskyttelse mod det ukendte..

Med ACTICOAT’s unikke patenterede sølvteknologi kan du nedbringe infektionsrisikoen i overfladiske og dybe sår.


ACTICOAT kills pathogensEffektiv mod 150+ patogener 

  • Bredspektret
    » grampositive bakterier
    » gramnegative bakteriaer
    » svampepatogener i sår.

Når kilden til bakteriel kontamination er ukendt, giver du dine patienter en forsvarlig beskyttelse med en bredspektret bandage, der har vist sig virkningsfuld (in vitro) mod 150+ sårpatogener6,9-11.


ACTICOAT starts working within 30 minutesHurtigtvirkende 

ACTICOAT's patenterede sølvteknologi betyder, at den begynder at virke inden for 30 minutter ved at reducere risikoen for, at bakterier kan udvikle antimikrobiel resistens.8-11


ACTICOAT Easy to Apply IconNem at applicere

ACTICOAT Flex tilpasser sig kroppens form. Det gør det nemmere for dig og dit team at forbinde sår, uanset hvor store og alvorlige de er, og hvor på kroppen de er 40.

Referencer

6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
8. Wright et al., The Comparative Efficacy of Two Antimicrobial Barrier Dressings: In-Vitro Examination of Two Controlled Release of Silver Dressings. Wounds 1998; 10(6): 179-188.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
40. Demonstrable. 

Svært helende sår

Whether they are diabetic ulcers, venous ulcers or pressure ulcers, chronic infections can be difficult to treat. Left unresolved, they can lead to prolonged patient suffering and increased healthcare costs. Taking control of infection is critical to patient outcome. 
In as little as 2 weeks ACTICOAT™ has been shown to reduce the signs and symptoms of infection and requires fewer dressing changes than other dressings, allowing you to treat more patients more effectively.25, 26
Fast-acting 
Gets to work rapidly, in as little as two weeks. ACTICOAT's proprietary silver technology is formulated to act rapidly, and can reduce the signs and symptoms of infection in as little as two weeks in infected chronic wounds.25
Sustained action
ACTICOAT continues to work effectively for
up to 3 or 7 days depending on wear time
resulting in:
Fewer dressing changes
Fewer visits with a clinician
Less overall nurse time
Kills 150+ pathogens 
150+ pathogens 
Broad spectrum 
gram-positive bacteria 
gram-negative bacteria
fungal wound pathogens6, 9-11 
ACTICOAT’s proprietary silver technology means that it is effective against a very broad spectrum of pathogens so you are equipped to reduce the signs and symptoms of infection in chronic wounds with complete confidence
Link to ACTICOAT Flex and Flex 7 

Kroniske infektioner er vanskelige at behandle, uanset om det er  diabetessår, venøse sår eller tryksår. Hvis de ikke behandles, kan de medføre langvarige gener for patienten og højere behandlingsomkostninger. Infektionsbekæmpelse er kritisk for ophelingsresultatet hos patienten. 

I løbet af blot 2 uger kan ACTICOAT reducere tegnene og symptomerne på infektion og kræver færre bandageskift end andre bandager, så du kan behandle flere patienter mere effektivt.25, 26


ACTICOAT Clock IconVirker hurtigt 

Virker hurtigt, på blot to uger. ACTICOAT's ACTICOATs patenterede sølvteknologi er udviklet til at virke hurtigt og kan reducere tegn og symptomer på infektion på blot 2 uger i inficerede, svært helende sår.25


ACTICOAT Sustained Action SymbolVedvarende virkning 

ACTICOAT fortsætter med at virke effektivt i op til 3 eller 7 dage5,35,36 afhængigt af bæretiden, hvilket betyder:
» Færre bandageskift;
» Færre besøg hos klinikeren;
» Mindre behandlingstid samlet set.


ACTICOAT kills pathogensEffektiv mod 150+ patogener  

  • 150+ patogener6
  • Bredspektret6
    » grampositive bakterier 
    » gramnegative bakterier 
    » svampepatogener i sår. 

ACTICOAT’s patenterede sølvteknologi betyder, at den er effektiv over for et meget bredt spektrum af patogener, så du er godt klædt på til at reducere tegn og symptomer på infektion i svært helende sår25.

Referencer

5. Westaim 971030
6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
25. Gago M, et al., A comparison of three silver-containing dressings in the treatment of infected, chronic wounds. Wounds 2008; 20 (10): 273-278.
26. Searle and Bielby. Dressing strategies for the management of infected wounds in community wound care: impacts and implications. Poster at Wounds UK, Harrogate Nov 2010.
35. Westaim Report Ref #001213 Long Term Comparative Evaluation of Silverlon and ACTICOAT 7 Dressings against MRSA.
36. Westaim Report Ref. #010322 Seven Day Efficacy of ACTICOAT 7 Dressings against multiple organisms. 

Kirurgiske incisioner

Your choice of post-operative dressing may significantly impact your re-admission rates and related healthcare costs. Without a fast-acting, effective antimicrobial barrier dressing after surgery, patients could be left at serious risk of surgical site infections (SSIs).
ACTICOAT™ Surgical protects your patients against the most common bacteria in each of these surgical situations and many more. Be proactive against infection risk in your surgical procedures with ACTICOAT.
Effective barrier to bacterial penetration 
Once applied, ACTICOAT Surgical is a near-complete barrier to the penetration or spread of infection, protecting your surgical incision from infection risk.32
Sustained action 
ACTICOAT Surgical continues to work effectively up to seven days, leaving you safe in the knowledge that your incision is protected once a patient has left hospital: 
Fewer dressing changes » Fewer HCP visits » Less overall nurse time
Easy-to-use 
ACTICOAT Surgical adhesive foam post-operative dressing has a fenestrated pad for added conformability 
Easy to apply » Causes minimal trauma to the site when removed, saving time and helping to ensure the patient complies with your post-operative care
Compatible with NPWT 
ACTICOAT Flex 3 and Flex 7 can be used in combination with NPWT for up to 3 days.
Link to ACTICOAT Surgical Product page

Dit valg af postoperativ bandage kan have en markant indflydelse på genindlæggelsesfrekvensen og relaterede behandlingsomkostninger.

Patienten kan have en alvorlig risiko for post-operative infektioner (surgical site infections/SSI)  uden en hurtigtvirkende og effektiv antimikrobiel barrierebandage efter operationen.

ACTICOAT for Surgical Incisions

ACTICOAT Surgical beskytter patienterne mod de mest almindeligt forekommende bakterier i disse operationssituationer og mange flere. Vær proaktiv mod infektionsrisici i din kirurgiske procedure med ACTICOAT.


ACTICOAT Barrier IconEffektiv barriere mod bakteriel indtrængning 

Når ACTICOAT Surgical bandagen er anlagt, udgør den en næsten fuldstændig barriere mod indtrængning eller spredning af infektion, og beskytter operationssåret mod infektionsrisici.32


ACTICOAT Sustained Action SymbolVedvarende virkning 

ACTICOAT Surgical bliver ved med at fungere effektivt i op til 7 dage33, så du kan være sikker på, at operationssåret er beskyttet, når patienten har forladt hospitalet:

»Færre bandageskift
» Færre kliniker besøg
» Mindre behandlingstid samlet set


ACTICOAT Easy to Apply IconBrugervenlig 

ACTICOAT Surgical er en hæftende, postoperativ skumbandage med en perforeret pude, der giver ekstra formbarhed43.

»Let at applicere
»Giver minimalt traume på stedet, når den fjernes, hvilket sparer tid og sikrer, at patienten kan modtage den postoperative pleje.


ACTICOAT Combination IconKompatibel med NPWT

ACTICOAT Flex 3 og Flex 7 kan anvendes i kombination med NPWT i op til 3 dage42.

Referencer

27. Whitehouse JD et al., The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002; 23(4):183-9.
28. Edwards JE et al., National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783-805.
30. Harris MS, MSM, BS, MT/CLS(ASCP), CIC MHS Infection Prevention; Evelyn Hickson, RN, MSN, CNS, WCC Perinatal Clinical Nurse Specialist, Using a multi-faceted active change process and infection prevention to reduce post-op C-section infections.
32. Vaughan, Bacterial barrier testing (wet/wet) on samples of ACTICOAT Post-op, Smith & Nephew Research Centre work Report, Project number TW092, Activity number 130, Work report reference number: WRP-TW092-130-01, 2007.
33. Gaw (200&) Ref: 0708058 An in-vitro Assessment of the Bacterial Log Reduction Properties Induced by Silver Containing ACTICOAT Post-op Dressings.
42. Smith & Nephew Data on File 0810010.
43. Demonstrable. 

Contact Us

ACTICOATDiscover more about ACTICOAT

Get in Touch